Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: Data from Southwest Oncology Group trial 9346 (INT-0162)


Hussain M., Tangen C. M. , Higano C., Schelhammer P. F. , Faulkner J., Crawford E. D. , ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.24, sa.24, ss.3984-3990, 2006 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 24 Konu: 24
  • Basım Tarihi: 2006
  • Doi Numarası: 10.1200/jco.2006.06.4246
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY
  • Sayfa Sayıları: ss.3984-3990

Özet

Purpose To establish whether absolute prostate-specific antigen (PSA) value after androgen deprivation (AD) is prognostic in metastatic (D2) prostate cancer (PCa).